My ePortfolio Register   

Asia-Pacific approaches to myeloma trials

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 03.03.17
Views: 1011

Prof Chng Wee Joo - National University Health System, Singapore, Singapore

Prof Chng speaks with ecancer at the 16th International Myeloma Workshop about the landscape of current international trials in multiple myeloma, focusing on Asia-Pacific countries. 

He highlights the issues in variation of clinical practice and drug accessibility in the region, and why a clinical trial network has been set up.

ecancer's filming has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.

Related videos

follow us

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence